A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization.This report primarily focuses on bacterial nosocomial infections with some mention of viral infections. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the hospital setting, and b) the practical aspects of diagnosis and therapy are more meaningful based both on medical considerations and on market considerations.
Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends Published: July 2011 No. of Pages: 150 Price: $3995 A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections). The following market data is provided in this report: • Hospital-Acquired Infections Diagnostics Markets • Forecast for HAI Diagnostics to 2015 • HAI Tests on the Market • Market for Diagnostics by Infection Type (C. Diff., MRSA, Pneumonia, Other) • Molecular HAI Market vs. Conventional HAI Market, Present and in 2015 • Geographic Breakdown of Testing (U.S., Europe, Asia, ROW) • New Hospital Infection Product Testing Products in the Market • Company Profiles • Treatment Products on the Market, HAI Antibiotic market Size and Forecast Both diagnostics and treatment segments have unique circumstances for growth which are discussed in detail in the report. Worldwide, both segments combined are worth more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion. The market has shown an increase of 3% annually with sales increasing from $7.9 billion in 2005. Although the treatment segment will continue to struggle to maintain growth, the testing segment will offset declines beginning in 2012. Browse All: Biotechnology Market Research This report primarily focuses on bacterial nosocomial infections with some mention of viral infections. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the hospital setting, and b) the practical aspects of diagnosis and therapy are more meaningful based both on medical considerations and on market considerations. Some of the issues discussed in this report include: • Development of Potential Life-Saving Products • Development of Fast Testing Systems • Growing Drug Resistance • Development of Better Pharmacodiagnostics • Market Opportunity and Growth Rates Expected in Diagnostics versus Treatment • Hospital Procedures for Use of Testing and Antibiotics • Attention to Special Population Issues • Demographics and Epidemiology • New Government Guidelines and Requirements for Preventing Infection • Focus on Alliances and Partnerships Market analysis in this report considers primarily the epidemiological considerations and the size of patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital environment in order to try and construct a picture of the nosocomial testing and treatment needs. The primary focus of this report is on the bacterial form of nosocomial infections, and those with significant impact on the hospital setting and markets. In looking at these infections, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends in these product areas. To some extent, we are limited by the activity of the industries associated with the diagnosis and treatment of these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology. The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, research scientists, business development managers and marketing managers. TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY Overview Infection Control Summary Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Molecular Testing vs. Conventional Testing Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS Overview Introduction to Pathogens Classification of Antibacterial Organisms Common Hospital (nosocomial) Infections Description of Infections Acinetobacter Baumannii Clostridium Difficile Gastroenteritis Hospital-Acquired Pneumonia (HAP) Pseudomonas Aeruginosa Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus Stenotrophomonas Maltophilia Tuberculosis Urinary Tract Infections Vancomycin-Resistant Enterococcus Hospital Units and Infection Risks Burn Units Intensive Care Units Emergency Departments Principles of Anti-bacterial Therapy Infecting Organism Antibiotic Sensitivity Testing Site of Infection Host Defenses and Organ Function Antibiotic Pharmacokinetics Monitoring Therapy General Infection Statistics Nosocomial Infection Statistics Populations at Risk for Infection Demographics of the World Infections and Drug Resistance Causes of Drug Resistance Antibiotic Abuse Antibiotic Use in Agriculture Drug Resistance in Select Populations Children The Elderly Compromised Individuals Measures for Reducing Resistance Antibiotic Cycling Antibiotic Education Screening Hospitalized patients The American Recovery and Reinvestment Act of 2009 Financial Impact of Hospital Infections State Level Case Study of HAI Admissions and Readmissions Manufacturer and Marketer Trends Trends in Partnerships and Alliances Developers Trends CHAPTER THREE: HOSPITAL INFECTION DIAGNOSTICS Overview Methods of Transmission Airborne Contact Direct-Contact Transmission Indirect-Contact Transmission Droplet Vehicle Prevention Measures Testing Drug-Resistance/Susceptibility Testing Genotypic Methods DNA Sequencing Solid-phase Hybridization Techniques Microarrays Real-time Polymerase Chain Reaction Techniques Phenotypic Methods Phage-based Assays Colorimetric Methods The Nitrate Reductase Assay Nosocomial Disease Testing Acinetobacter Baumannii Clostridium Difficile Hospital-Acquired Pneumonia Ventilator-Associated Pneumonia Pseudomonas Aeruginosa Staphylococcus Aureus Tuberculosis Urinary Tract Infections New Developments Market Overview Total Market Size and Forecast HAI Testing by Infection Type Hospital Infection Testing Market by Geographical Region Molecular Testing vs. Conventional Testing. Market and Forecast for Molecular HAI Competitors in HAI Testing CHAPTER FOUR: TREATING HOSPITAL INFECTIONS Overview Treatment Guidelines Clostridium Difficile Gastroenteritis Hospital-Acquired Pneumonia Ventilator-associated Pneumonia Pseudomonas Aeruginosa Staphylococcus Aureus Stenotrophomonas maltophilia Tuberculosis Urinary Tract Infections Recent Drug Approvals Market Overview CHAPTER FIVE: MARKET SUMMARY Market Considerations Market Overview Regional Breakdown of Market Competitive Summary CHAPTER SIX: COMPANY PROFILES Introduction Abbott Laboratories AdvanDx, Inc. Alere AstraZeneca Bayer Healthcare Pharmaceuticals (Bayer Schering Pharma) v Becton, Dickinson Cepheid Cubist Pharmaceuticals Daiichi Sankyo Diatherix Laboratories Inc. Gen-Probe Inc. GlaxoSmithKline Johnson & Johnson Merck & Co. Meridian Bioscience, Inc. Pfizer Roche Seegene, Inc. APPENDIX: LIST OF MAJOR PROVIDERS LIST OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY Table 1-2: The Global Market for Hospital Infections by Product Segment (Diagnostics, Treatment), 2005-2015 Figure 1-1: The Global Market for Hospital Infections 2005-2015 Figure 1-2: Growth Rate - HAI Diagnostic Market vs. HAI Treatment Market Table 1-3: MRSA Risk and Testing Priority CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS Table 2-1: Antibiotics with Difficult Penetration Table 2-2: Common Nosocomial Infections Table 2-3: Risk Factors for M. tuberculosis Table 2-4: Common ICU Infections Table 2-5: Estimated World and U.S. Incidence of Bacterial Infections Figure 2-1: Estimated World and U.S. Incidence of Bacterial Infections Figure 2-2: U.S. Hospital Admissions, Percent Acquiring HAIs Table 2-6: World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region (World, U.S., Europe), 2010 Figure 2-3: World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region, 2010 Table 2-4: Estimated World Population by Age and Geographical Region, 2010 Figure 2-4: Estimated World Population by Age and Geographical Region, 2010 Table 2-5: Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2009 Table 2-6: Pennsylvania State Analysis of HAIs, 2009 CHAPTER THREE: HOSPITAL INFECTION DIAGNOSTICS Table 3-1: CDC Healthcare Setting Guidelines Table 3-2: MRSA Risk and Testing Priority Table 3-3: Recent Approvals for Hospital Infection Testing (Product, Company, Description of Test, Approved Regions) Table 3-4: New Developments, Hospital Infection Testing (Developer, Description, Status, Indication) Table 3-5: The World Market for Hospital Infection Testing/Diagnostics 2005-2015 (Revenues, Percent Change) Figure 3-1: The World Market for Hospital Infection Testing/Diagnostics 2005-2015 Figure 3-2: Distribution of Revenues for HAI Testing by Infection Type, 2010 Estimates (MRSA, Cdiff, Other HAIs) Table 3-6: The World Market for Hospital Infection Testing/Diagnostics Estimated Products Sales by Geographic Region (US, Europe, ROW) 2005-2015 Figure 3-3: The World Market for Hospital Infection Testing/Diagnostics Estimated Product Sales by Geographic Region (US, Europe, ROW) 2005-2015 Table 3-7: Detection Time for MRSA by Screening Method (Test Type, Turnaround Time, Average Cost) Figure 3-4: Molecular vs. Conventional Diagnostic Market for HAIs in 2010 and Projected to 2015 Table 3-8: The World Market for Hospital Infection Diagnostics (Top 9 Leading Suppliers vs. Others) 2010 CHAPTER FOUR: TREATING HOSPITAL INFECTIONS Table 4-1: Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer) Table 4-3: Recent Approvals for Hospital Infection Treatments Table 4-5: The World Market for Hospital Infection Treatment 2005-2015 Figure 4-3: The World Market for Hospital Infection Treatment Estimated Market Share by Region, 2010 CHAPTER FIVE: MARKET SUMMARY Table 5-1: The Global Market for Hospital Infections by Product Segment, 2005-2015 Figure 5-1: The Global Market for Hospital Infection Products 2005-2015 Figure 5-2: The Global Market for Hospital Infection Products by Product Segment, 2010 (Diagnostics, Treatment) About Us: ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Follow us on Twitter: http://twitter.com/marketsreports Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689 Contact: Mr.Priyank 7557 Rambler road, Suite727,Dallas,TX75231 Tel: +1-888-989-8004 E-mail: firstname.lastname@example.org http://www.reportsnreports.com Visit our Market Research Blog
Pages to are hidden for
"ReportsnReports.com: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends"Please download to view full document